Weight management can involve more than diet and physical activity alone, especially for adults living with overweight, obesity, or related health conditions. **Semaglutide oral for weight loss** is a treatment option that has gained attention, as semaglutide is a GLP-1 receptor agonist that can influence appetite and food intake.

In 2026, **oral semaglutide** is available in the United States in an FDA-approved Wegovy tablet formulation for specific weight-management indications. However, patients should distinguish between FDA-approved products and other formulations available through different treatment pathways. The specific medication, formulation, dosage, and eligibility should always be determined by an appropriately licensed healthcare provider.